Can Biosignatures Be Used to Develop a Reliable, Fast and Low-Cost Test for Tuberculosis?

Stefan H. E. Kaufmann

Tuberculosis is still a major health issue and the number one killer of all contagious diseases. But while more than 2 billion people are infected with the tuberculosis agent, only 10% develop an active disease. Current diagnostic tests cannot distinguish between infected people and people with active tuberculosis. In this video, STEFAN H. E. KAUFMANN explains that they found a characteristic gene expression profile of people infected with tuberculosis. Relying on only four markers they developed a highly sensitive method that is not only able to identify people with active tuberculosis but is also suitable for point of care application in countries with low resources.

DOI:

https://doi.org/10.21036/LTPUB10210

Researcher

Stefan H.E. Kaufmann is a Founding Director of the Max Planck Institute for Infection Biology, Berlin, and Professor for Microbiology and Immunology at the Charité University Clinics, Berlin. Kaufmann used to be the president of the German Society for Immunology and is a member of the German National Academy of Sciences Leopoldina. As a leading researcher in the field of immunology, Kaufmann identifies tuberculosis as a continued health threat and explores how to make tuberculosis treatments more affordable and effective in the face of multi-resistant tuberculosis.

Max Planck Institute for Infection Biology

The Max Planck Institute for Infection Biology focuses on understanding how microbes cause disease and how hosts respond to this challenge. Its mission is to understand infections by viruses, bacteria, parasites, fungi and worms of two reasons: they present one of the most significant medical burdens on earth and the interaction between microbes and their host are an essential driver of evolution. To find answers to the fundamental questions of infection biology, the MPIIB brings together scientists from various disciplines. Hence the scale of the MPIIB research spans through the atomic, molecular, cellular, tissular, organismal, clinical and finally social level. The Institute is located at the historical Campus of the Charité Clinic in the heart of Berlin.

Can Biosignatures Be Used to Develop a Reliable, Fast and Low-Cost Test for Tuberculosis?

Researcher

Original Publication

Concise Gene Signature for Point-Of-Care Classification of Tuberculosis

Jeroen Maertzdorf

Gayle K. McEwen

January Weiner

Tian Song

Eric Lader